• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

没食子酸丙酯和辛可宁酸,组蛋白乙酰转移酶天然抑制剂,抑制横纹肌肉瘤生长和增殖。

Garcinol and Anacardic Acid, Natural Inhibitors of Histone Acetyltransferases, Inhibit Rhabdomyosarcoma Growth and Proliferation.

机构信息

Institute of Physical Culture Sciences, University of Szczecin, 70-453 Szczecin, Poland.

Department of Physiology in Health Sciences, Pomeranian Medical University in Szczecin, 71-210 Szczecin, Poland.

出版信息

Molecules. 2023 Jul 8;28(14):5292. doi: 10.3390/molecules28145292.

DOI:10.3390/molecules28145292
PMID:37513165
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10383693/
Abstract

Rhabdomyosarcoma (RMS) is a malignant tumour of the soft tissues. There are two main histopathological types: alveolar and embryonal. RMS occurs mainly in childhood and is a result of the deregulation of growth and differentiation of muscle cell precursors. There is an increasing amount of data indicating that numerous epigenetic alterations within chromatin and histone proteins are involved in the pathogenesis of this malignancy. Histone acetylation is one of the most important epigenetic modifications that is catalysed by enzymes from the group of histone acetyltransferases (HAT). In this study, the impact of the natural histone acetyltransferase inhibitors (HATi)-garcinol (GAR) and anacardic acid (AA)-on the biology of RMS cells was evaluated through a series of in vitro tests measuring proliferation, viability, clonogenicity, cell cycle and apoptosis. Moreover, using oligonucleotide microarrays and real-time PCR, we identified several genes whose expression changed after GAR and AA treatment. The examined HATi significantly reduce the invasive phenotype of RMS cells by inhibiting the growth rate, viability and clonogenic abilities. What is more, these substances cause cell cycle arrest in the G2/M phase, induce apoptosis and affect the genetic expression of the endoplasmic reticulum stress sensors. GAR and AA may serve as promising potential anti-cancer drugs since they sensitize the RMS cells to chemotherapeutic treatment.

摘要

横纹肌肉瘤(RMS)是一种软组织恶性肿瘤。有两种主要的组织病理学类型:肺泡和胚胎型。RMS 主要发生在儿童时期,是肌肉细胞前体生长和分化失调的结果。越来越多的数据表明,染色质和组蛋白蛋白内的许多表观遗传改变参与了这种恶性肿瘤的发病机制。组蛋白乙酰化是最重要的表观遗传修饰之一,由组蛋白乙酰转移酶(HAT)组中的酶催化。在这项研究中,通过一系列体外试验,评估了天然组蛋白乙酰转移酶抑制剂(HATi)-garcinol(GAR)和 anacardic acid(AA)对 RMS 细胞生物学的影响,这些试验测量了增殖、活力、集落形成能力、细胞周期和细胞凋亡。此外,使用寡核苷酸微阵列和实时 PCR,我们鉴定了 GAR 和 AA 处理后表达发生变化的几个基因。这些被检测到的 HATi 通过抑制 RMS 细胞的生长速度、活力和集落形成能力显著降低了其侵袭表型。更重要的是,这些物质导致细胞周期停滞在 G2/M 期,诱导细胞凋亡,并影响内质网应激传感器的基因表达。GAR 和 AA 可能作为有前途的潜在抗癌药物,因为它们使 RMS 细胞对化疗敏感。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e0/10383693/5ad095360ff0/molecules-28-05292-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e0/10383693/9e3247371277/molecules-28-05292-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e0/10383693/13b05b25799c/molecules-28-05292-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e0/10383693/43550d8ca012/molecules-28-05292-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e0/10383693/dcc563c0c19a/molecules-28-05292-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e0/10383693/03b48bdb4272/molecules-28-05292-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e0/10383693/274838aab9c9/molecules-28-05292-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e0/10383693/c071a7230408/molecules-28-05292-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e0/10383693/6a14027fb68a/molecules-28-05292-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e0/10383693/b242b0b5d8a5/molecules-28-05292-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e0/10383693/5ad095360ff0/molecules-28-05292-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e0/10383693/9e3247371277/molecules-28-05292-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e0/10383693/13b05b25799c/molecules-28-05292-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e0/10383693/43550d8ca012/molecules-28-05292-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e0/10383693/dcc563c0c19a/molecules-28-05292-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e0/10383693/03b48bdb4272/molecules-28-05292-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e0/10383693/274838aab9c9/molecules-28-05292-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e0/10383693/c071a7230408/molecules-28-05292-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e0/10383693/6a14027fb68a/molecules-28-05292-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e0/10383693/b242b0b5d8a5/molecules-28-05292-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e0/10383693/5ad095360ff0/molecules-28-05292-g010.jpg

相似文献

1
Garcinol and Anacardic Acid, Natural Inhibitors of Histone Acetyltransferases, Inhibit Rhabdomyosarcoma Growth and Proliferation.没食子酸丙酯和辛可宁酸,组蛋白乙酰转移酶天然抑制剂,抑制横纹肌肉瘤生长和增殖。
Molecules. 2023 Jul 8;28(14):5292. doi: 10.3390/molecules28145292.
2
Differential effects of garcinol and curcumin on histone and p53 modifications in tumour cells.姜黄素和没食子酸对肿瘤细胞组蛋白和 p53 修饰的差异影响。
BMC Cancer. 2013 Jan 29;13:37. doi: 10.1186/1471-2407-13-37.
3
Characterization of novel inhibitors of histone acetyltransferases.组蛋白乙酰转移酶新型抑制剂的特性研究
Mol Cancer Ther. 2007 Sep;6(9):2391-8. doi: 10.1158/1535-7163.MCT-07-0159.
4
Assays for Validating Histone Acetyltransferase Inhibitors.用于验证组蛋白乙酰转移酶抑制剂的检测方法。
J Vis Exp. 2020 Aug 6(162). doi: 10.3791/61289.
5
Histone acetyltransferase inhibitor II induces apoptosis in glioma cell lines via the p53 signaling pathway.组蛋白乙酰转移酶抑制剂II通过p53信号通路诱导胶质瘤细胞系凋亡。
J Exp Clin Cancer Res. 2014 Dec 19;33(1):108. doi: 10.1186/s13046-014-0108-3.
6
Protein Arginine Methyltransferase (PRMT) Inhibitors-AMI-1 and SAH Are Effective in Attenuating Rhabdomyosarcoma Growth and Proliferation in Cell Cultures.蛋白精氨酸甲基转移酶(PRMT)抑制剂-AMI-1 和 SAH 可有效抑制细胞培养中的横纹肌肉瘤生长和增殖。
Int J Mol Sci. 2021 Jul 27;22(15):8023. doi: 10.3390/ijms22158023.
7
Chemosensitization of rhabdomyosarcoma cells by the histone deacetylase inhibitor SAHA.组蛋白去乙酰化酶抑制剂 SAHA 对横纹肌肉瘤细胞的化学增敏作用。
Cancer Lett. 2014 Aug 28;351(1):50-8. doi: 10.1016/j.canlet.2014.04.021. Epub 2014 May 6.
8
Trichostatin A Inhibits Rhabdomyosarcoma Proliferation and Induces Differentiation through MyomiR Reactivation.曲古抑菌素A通过激活肌源性微小RNA抑制横纹肌肉瘤增殖并诱导其分化。
Folia Biol (Praha). 2019;65(1):43-52. doi: 10.14712/fb2019065010043.
9
OBP‑801, a novel histone deacetylase inhibitor, induces M‑phase arrest and apoptosis in rhabdomyosarcoma cells.OBP-801,一种新型组蛋白去乙酰化酶抑制剂,可诱导横纹肌肉瘤细胞的 M 期阻滞和凋亡。
Oncol Rep. 2019 Jan;41(1):643-649. doi: 10.3892/or.2018.6813. Epub 2018 Oct 22.
10
Repurposing proscillaridin A in combination with decitabine against embryonal rhabdomyosarcoma RD cells.普司他汀 A 与地西他滨联合应用于胚胎性横纹肌肉瘤 RD 细胞的再利用。
Cancer Chemother Pharmacol. 2021 Nov;88(5):845-856. doi: 10.1007/s00280-021-04339-6. Epub 2021 Jul 31.

引用本文的文献

1
Molecular Targets in Alveolar Rhabdomyosarcoma: A Narrative Review of Progress and Pitfalls.肺泡横纹肌肉瘤的分子靶点:进展与陷阱的叙述性综述
Int J Mol Sci. 2025 May 28;26(11):5204. doi: 10.3390/ijms26115204.
2
Genetic dysregulation of EP300 in cancers in light of cancer epigenome control - targeting of p300-proficient and -deficient cancers.基于癌症表观基因组控制视角下癌症中EP300的基因失调——针对具有野生型和缺失型p300的癌症
Mol Ther Oncol. 2024 Sep 2;32(4):200871. doi: 10.1016/j.omton.2024.200871. eCollection 2024 Dec 19.
3
Combinatory Effect of Pequi Oil ()-Based Nanoemulsions Associated to Docetaxel and Anacardic Acid () in Triple-Negative Breast Cancer Cells In Vitro.

本文引用的文献

1
Natural Bioactive Compounds Targeting Epigenetic Pathways in Cancer: A Review on Alkaloids, Terpenoids, Quinones, and Isothiocyanates.天然生物活性化合物靶向癌症表观遗传途径:生物碱、萜类化合物、醌类和异硫氰酸盐的综述。
Nutrients. 2021 Oct 22;13(11):3714. doi: 10.3390/nu13113714.
2
Protein Arginine Methyltransferase (PRMT) Inhibitors-AMI-1 and SAH Are Effective in Attenuating Rhabdomyosarcoma Growth and Proliferation in Cell Cultures.蛋白精氨酸甲基转移酶(PRMT)抑制剂-AMI-1 和 SAH 可有效抑制细胞培养中的横纹肌肉瘤生长和增殖。
Int J Mol Sci. 2021 Jul 27;22(15):8023. doi: 10.3390/ijms22158023.
3
Garcinol-A Natural Histone Acetyltransferase Inhibitor and New Anti-Cancer Epigenetic Drug.
基于瓜拉那油()的纳米乳液与多西他赛和漆树酸()联合对三阴性乳腺癌细胞的体外作用。
Pharmaceutics. 2024 Sep 5;16(9):1170. doi: 10.3390/pharmaceutics16091170.
4
Fluoride Alters Gene Expression via Histone H3K27 Acetylation in Ameloblast-like LS8 Cells.氟化物通过 LS8 细胞中组蛋白 H3K27 乙酰化改变基因表达。
Int J Mol Sci. 2024 Sep 4;25(17):9600. doi: 10.3390/ijms25179600.
5
The Role of T-Cadherin (CDH13) in Treatment Options with Garcinol in Melanoma.T-钙黏蛋白(CDH13)在藤黄脂素治疗黑色素瘤的方案中的作用。
Cancers (Basel). 2024 May 12;16(10):1853. doi: 10.3390/cancers16101853.
6
The epigenetic regulatory effect of histone acetylation and deacetylation on skeletal muscle metabolism-a review.组蛋白乙酰化和去乙酰化对骨骼肌代谢的表观遗传调控作用——综述
Front Physiol. 2023 Dec 8;14:1267456. doi: 10.3389/fphys.2023.1267456. eCollection 2023.
藤黄脂素——一种天然组蛋白乙酰转移酶抑制剂及新型抗癌表观遗传药物。
Int J Mol Sci. 2021 Mar 11;22(6):2828. doi: 10.3390/ijms22062828.
4
Updates from the 2020 World Health Organization Classification of Soft Tissue and Bone Tumours.2020 年世界卫生组织软组织和骨肿瘤分类更新。
Histopathology. 2021 Apr;78(5):644-657. doi: 10.1111/his.14265. Epub 2021 Jan 12.
5
The 2020 WHO Classification of Tumors of Soft Tissue: Selected Changes and New Entities.《2020 年世卫组织软组织肿瘤分类:精选变更和新实体》。
Adv Anat Pathol. 2021 Jan;28(1):44-58. doi: 10.1097/PAP.0000000000000284.
6
Anti-Inflammatory, Antinociceptive, and Antioxidant Properties of Anacardic Acid in Experimental Models.实验模型中漆树酸的抗炎、抗伤害感受和抗氧化特性
ACS Omega. 2020 Jul 29;5(31):19506-19515. doi: 10.1021/acsomega.0c01775. eCollection 2020 Aug 11.
7
Garcinol Alone and in Combination With Cisplatin Affect Cellular Behavior and PI3K/AKT Protein Phosphorylation in Human Ovarian Cancer Cells.藤黄脂单独及与顺铂联合对人卵巢癌细胞的细胞行为及PI3K/AKT蛋白磷酸化的影响
Dose Response. 2020 May 19;18(2):1559325820926732. doi: 10.1177/1559325820926732. eCollection 2020 Apr-Jun.
8
Garcinol Exhibits Anti-Neoplastic Effects by Targeting Diverse Oncogenic Factors in Tumor Cells.藤黄脂通过靶向肿瘤细胞中的多种致癌因子发挥抗肿瘤作用。
Biomedicines. 2020 Apr 30;8(5):103. doi: 10.3390/biomedicines8050103.
9
Current and Future Treatment Strategies for Rhabdomyosarcoma.横纹肌肉瘤的当前及未来治疗策略
Front Oncol. 2019 Dec 20;9:1458. doi: 10.3389/fonc.2019.01458. eCollection 2019.
10
The timeline of epigenetic drug discovery: from reality to dreams.表观遗传学药物发现的时间轴:从现实到梦想。
Clin Epigenetics. 2019 Dec 2;11(1):174. doi: 10.1186/s13148-019-0776-0.